Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,000 | 2 | 99.9% |
| Food and Beverage | $23.73 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Development Center Americas, Inc. | $21,000 | 2 | $0 (2017) |
| Janssen Pharmaceuticals, Inc | $12.79 | 1 | $0 (2019) |
| Puma Biotechnology, Inc. | $10.94 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2019 | $23.73 | 2 | Janssen Pharmaceuticals, Inc ($12.79) |
| 2017 | $21,000 | 2 | Takeda Development Center Americas, Inc. ($21,000) |
All Payment Transactions
4 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/30/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $10.94 | General |
| Category: Oncology | ||||||
| 04/02/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $12.79 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/31/2017 | Takeda Development Center Americas, Inc. | — | Consulting Fee | Cash or cash equivalent | $15,000.00 | General |
| 02/28/2017 | Takeda Development Center Americas, Inc. | — | Consulting Fee | Cash or cash equivalent | $6,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 12 | 13 | $1,209 | $143.53 |
| 2022 | 8 | 137 | 281 | $35,879 | $5,603 |
| 2021 | 7 | 118 | 235 | $32,763 | $6,331 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 12 | 13 | $1,209 | $143.53 | 11.9% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 24 | 24 | $19,582 | $2,622 | 13.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $2,528 | $1,004 | 39.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 13 | 13 | $3,952 | $703.16 | 17.8% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2022 | 17 | 35 | $3,675 | $444.61 | 12.1% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 11 | 17 | $2,584 | $408.73 | 15.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 31 | 34 | $3,162 | $386.34 | 12.2% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2022 | 14 | 14 | $266.00 | $20.67 | 7.8% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 13 | 130 | $130.00 | $12.57 | 9.7% |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | Office | 2021 | 21 | 21 | $14,406 | $2,489 | 17.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 16 | 16 | $4,829 | $1,679 | 34.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | Office | 2021 | 18 | 19 | $5,776 | $1,060 | 18.4% |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | Office | 2021 | 11 | 19 | $2,888 | $487.84 | 16.9% |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | Office | 2021 | 17 | 24 | $2,520 | $328.32 | 13.0% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 24 | 24 | $2,232 | $274.56 | 12.3% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 11 | 112 | $112.00 | $12.92 | 11.5% |
About Dr. Bruce Booth, MD
Dr. Bruce Booth, MD is a Hematology & Oncology healthcare provider based in Newport News, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/17/2005. The National Provider Identifier (NPI) number assigned to this provider is 1164427993.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Booth, MD has received a total of $21,024 in payments from pharmaceutical and medical device companies, with $23.73 received in 2019. These payments were reported across 4 transactions from 3 companies. The most common payment nature is "Consulting Fee" ($21,000).
As a Medicare-enrolled provider, Booth has provided services to 267 Medicare beneficiaries, totaling 529 services with total Medicare billing of $12,077. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Location Newport News, VA
- Active Since 06/17/2005
- Last Updated 09/22/2014
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1164427993
Products in Payments
- XARELTO (Drug) $12.79
- Nerlynx (Drug) $10.94
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Newport News
David Chang, M.d., Phd, M.D., PHD
Hematology & Oncology — Payments: $84,986
Frankie Powell, Md, MD
Hematology & Oncology — Payments: $4,566
Dr. Ligeng Tian, B.m, B.M
Hematology & Oncology — Payments: $4,095
Mashour Yousef, M.d, M.D
Hematology & Oncology — Payments: $815.18
Flavia Kostov, M.d, M.D
Hematology & Oncology — Payments: $470.43
Vihitha Thota, Md, MD
Hematology & Oncology — Payments: $236.43